The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling. Ugo Sardo, Prunelle Perrier, ..., Jean Personnaz, Thanina Medjbeur, Aurore Desquesnes, Lisa Cannizzo, ..., Léon Kautz, Blood 2024. DOI: 10.1182/blood.2023022724

A fully human anti-BMP6 antibody reduces the need for erythropoietin in rodent models of the anemia of chronic disease. Verena Petzer, Piotr Tymoszuk, ..., Léon Kautz, et al., Blood 2020. DOI: 10.1182/blood.2019004653

A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome. Sabrina Bondu, Anne‐Sophie Alary, ..., Léon Kautz, et al., Science Translational Medicine 2019. DOI: 10.1126/scitranslmed.aav5467

Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice. Richard Coffey, Ugo Sardo, Léon Kautz, et al., Physiological Reports 2018. DOI: 10.14814/phy2.13890

Immunoassay for human serum erythroferrone. Tomas Ganz, Grace Jung, ..., Léon Kautz, et al., Blood 2017. DOI: 10.1182/blood-2017-04-777987

Erythroferrone and matriptase‐2 independently regulate hepcidin expression. Sharraya Aschemeyer, Victoria R. Gabayan, ..., Léon Kautz, American Journal of Hematology 2017. DOI: 10.1002/ajh.24672